Lixing Chen went to his immigration appointment Sept. 15 just as he had the three times before, said his son, Andy Chen. Andy drove. When Chen went into the building for his appointment, Andy waited ...
Wolfe Research analyst Andy Chen downgraded Akero Therapeutics (AKRO) to Peer Perform from Outperform following Novo Nordisk’s (NVO) plan to ...
Syracuse, N.Y. — Lixing Chen went to his immigration appointment Sept. 15 just as he had the three times before, said his son, Andy Chen. Andy drove. When Chen went into the building for his ...
Hosted on MSN
89bio Stock Skyrockets After Roche’s $3.5B Buyout Offer: Retail Bullish, But A Wall Street Analyst Is Cautious
Wolfe Research’s Andy Chen cut his rating on 89bio to 'Peer Perform' from 'Outperform' and did not assign a price target after the biotech firm agreed to a $3.5 billion takeover by Roche. 89bio’s ...
These are the most significant crypto developments in Latin America this week, from Brazil’s bold move to establish Belo ...
16don MSN
How Syracuse’s property brothers built a real estate empire (Top stories for the week of Sept. 21)
Here are six stories for the week of Sept. 21, 2025. Subscribe to get the Syracuse.com Exclusives newsletter delivered to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results